AlloVir
ALVR
$0.77
Share price
2.93%
Change (1 day)
-81.96%
Change (1 year)
Categories
AlloVir (ALVR) - Cash on Hand
Cash on Hand as of December 2023 : $0.18 B
According to AlloVir's latest financial reports the company has $0.18 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
AlloVir - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.23 B | -5.77% |
| 2021-12-31 | $0.24 B | -30.37% |
| 2020-12-31 | $0.35 B | 182.62% |
| 2019-12-31 | $0.12 B | 467.94% |
| 2018-12-31 | $22.19 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 13.18% | 🇺🇸 USA |